Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin as adjunct therapy in type 1 diabetes mellitus (inTandem1)
NCT02384941Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Countries
- 2
01
Overview
A Phase 3 trial of sotagliflozin in type 1 diabetes mellitus (T1D), sponsored by Lexicon Pharmaceuticals, Inc.. Started Mar 2015; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02384941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02384941.